Cargando…
Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study
BACKGROUND: In resource-limited settings, sputum smear conversion is used to document treatment response. Many People living with HIV (PLHIV) are smear-negative at baseline. The Xpert MTB/RIF test can indirectly measure bacterial load through cycle threshold (ct) values. This study aimed to determin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170957/ https://www.ncbi.nlm.nih.gov/pubmed/34074248 http://dx.doi.org/10.1186/s12879-021-06220-6 |
_version_ | 1783702342108971008 |
---|---|
author | Namugenyi, Juliet Musaazi, Joseph Katamba, Achilles Kalyango, Joan Sendaula, Emmanuel Kambugu, Andrew Fehr, Jan Castelnouvo, Barbara Manabe, Yukari C. Ssengooba, Willy Sekaggya-Wiltshire, Christine |
author_facet | Namugenyi, Juliet Musaazi, Joseph Katamba, Achilles Kalyango, Joan Sendaula, Emmanuel Kambugu, Andrew Fehr, Jan Castelnouvo, Barbara Manabe, Yukari C. Ssengooba, Willy Sekaggya-Wiltshire, Christine |
author_sort | Namugenyi, Juliet |
collection | PubMed |
description | BACKGROUND: In resource-limited settings, sputum smear conversion is used to document treatment response. Many People living with HIV (PLHIV) are smear-negative at baseline. The Xpert MTB/RIF test can indirectly measure bacterial load through cycle threshold (ct) values. This study aimed to determine if baseline Xpert MTB/RIF could predict time to culture negativity in PLHIV with newly diagnosed TB. METHODS: A subset of 138 PLHIV from the ‘SOUTH’ study on outcomes related to TB and antiretroviral drug concentrations were included. Bacterial load was estimated by Mycobacterium Growth Indicator Tubes (MGIT) culture time-to-positivity (TTP) and Lowenstein Jensen (LJ) colony counts. Changes in TTP and colony counts were analyzed with Poisson Generalised Estimating Equations (GEE) and multilevel ordered logistic regression models, respectively, while time to culture negativity analysed with Cox proportional hazard models. ROC curves were used to explore the accuracy of the ct value in predicting culture negativity. RESULTS: A total of 81 patients (58.7%) were males, median age 34 (IQR 29 – 40) years, median CD4 cell count of 180 (IQR 68 – 345) cells/μL and 77.5% were ART naive. The median baseline ct value was 25.1 (IQR 21.0 – 30.1). A unit Increase in the ct value was associated with a 5% (IRR = 1.05 95% CI 1.04 – 1.06) and 3% (IRR = 1.03 95% CI 1.03 – 1.04) increase in TTP at week 2 and 4 respectively. With LJ culture, a patient’s colony grade was reduced by 0.86 times (0R = 0.86 95% CI 0.74 – 0.97) at week 2 and 0.84 times (OR = 0.84 95% CI 0.79 – 0.95 P = 0.002) at week 4 for every unit increase in the baseline ct value. There was a 3% higher likelihood of earlier conversion to negativity for every unit increase in the ct value. A ct cut point ≥28 best predicted culture negativity at week 4 with a sensitivity of 91. 7% & specificity 53.7% while a cut point ≥23 best predicted culture negativity at week 8. CONCLUSION: Baseline Xpert MTB/RIF ct values predict sputum conversion in PLHIV on anti-TB treatment. Surrogate biomarkers for sputum conversion in PLHIV are still a research priority. |
format | Online Article Text |
id | pubmed-8170957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81709572021-06-03 Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study Namugenyi, Juliet Musaazi, Joseph Katamba, Achilles Kalyango, Joan Sendaula, Emmanuel Kambugu, Andrew Fehr, Jan Castelnouvo, Barbara Manabe, Yukari C. Ssengooba, Willy Sekaggya-Wiltshire, Christine BMC Infect Dis Research Article BACKGROUND: In resource-limited settings, sputum smear conversion is used to document treatment response. Many People living with HIV (PLHIV) are smear-negative at baseline. The Xpert MTB/RIF test can indirectly measure bacterial load through cycle threshold (ct) values. This study aimed to determine if baseline Xpert MTB/RIF could predict time to culture negativity in PLHIV with newly diagnosed TB. METHODS: A subset of 138 PLHIV from the ‘SOUTH’ study on outcomes related to TB and antiretroviral drug concentrations were included. Bacterial load was estimated by Mycobacterium Growth Indicator Tubes (MGIT) culture time-to-positivity (TTP) and Lowenstein Jensen (LJ) colony counts. Changes in TTP and colony counts were analyzed with Poisson Generalised Estimating Equations (GEE) and multilevel ordered logistic regression models, respectively, while time to culture negativity analysed with Cox proportional hazard models. ROC curves were used to explore the accuracy of the ct value in predicting culture negativity. RESULTS: A total of 81 patients (58.7%) were males, median age 34 (IQR 29 – 40) years, median CD4 cell count of 180 (IQR 68 – 345) cells/μL and 77.5% were ART naive. The median baseline ct value was 25.1 (IQR 21.0 – 30.1). A unit Increase in the ct value was associated with a 5% (IRR = 1.05 95% CI 1.04 – 1.06) and 3% (IRR = 1.03 95% CI 1.03 – 1.04) increase in TTP at week 2 and 4 respectively. With LJ culture, a patient’s colony grade was reduced by 0.86 times (0R = 0.86 95% CI 0.74 – 0.97) at week 2 and 0.84 times (OR = 0.84 95% CI 0.79 – 0.95 P = 0.002) at week 4 for every unit increase in the baseline ct value. There was a 3% higher likelihood of earlier conversion to negativity for every unit increase in the ct value. A ct cut point ≥28 best predicted culture negativity at week 4 with a sensitivity of 91. 7% & specificity 53.7% while a cut point ≥23 best predicted culture negativity at week 8. CONCLUSION: Baseline Xpert MTB/RIF ct values predict sputum conversion in PLHIV on anti-TB treatment. Surrogate biomarkers for sputum conversion in PLHIV are still a research priority. BioMed Central 2021-06-01 /pmc/articles/PMC8170957/ /pubmed/34074248 http://dx.doi.org/10.1186/s12879-021-06220-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Namugenyi, Juliet Musaazi, Joseph Katamba, Achilles Kalyango, Joan Sendaula, Emmanuel Kambugu, Andrew Fehr, Jan Castelnouvo, Barbara Manabe, Yukari C. Ssengooba, Willy Sekaggya-Wiltshire, Christine Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title | Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title_full | Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title_fullStr | Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title_full_unstemmed | Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title_short | Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study |
title_sort | baseline xpert mtb/rif ct values predict sputum conversion during the intensive phase of anti-tb treatment in hiv infected patients in kampala, uganda: a retrospective study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170957/ https://www.ncbi.nlm.nih.gov/pubmed/34074248 http://dx.doi.org/10.1186/s12879-021-06220-6 |
work_keys_str_mv | AT namugenyijuliet baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT musaazijoseph baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT katambaachilles baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT kalyangojoan baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT sendaulaemmanuel baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT kambuguandrew baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT fehrjan baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT castelnouvobarbara baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT manabeyukaric baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT ssengoobawilly baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy AT sekaggyawiltshirechristine baselinexpertmtbrifctvaluespredictsputumconversionduringtheintensivephaseofantitbtreatmentinhivinfectedpatientsinkampalaugandaaretrospectivestudy |